{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:58:56Z","timestamp":1762498736973,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.euf.2023.03.015","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T08:24:47Z","timestamp":1680251087000},"page":"409-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Confusion Surrounding Androgen Deprivation Therapy and Cognitive Dysfunction"],"prefix":"10.1016","volume":"9","author":[{"given":"Michael J.","family":"Pierro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Kilari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2023.03.015_b0005","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cncr.20955","article-title":"Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma","volume":"103","author":"Shahinian","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2023.03.015_b0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/95.13.981","article-title":"National practice patterns and time trends in androgen ablation for localized prostate cancer","volume":"95","author":"Cooperberg","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2023.03.015_b0015","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2023.03.015_b0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cncr.30320","article-title":"Effects of long-term androgen deprivation therapy on cognitive function over 36 months in men with prostate cancer","volume":"123","author":"Alibhai","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.euf.2023.03.015_b0025","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1200\/JCO.2014.60.1963","article-title":"Course and predictors of cognitive function in patients with prostate cancer receiving androgen-deprivation therapy: a controlled comparison","volume":"33","author":"Gonzalez","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2023.03.015_b0030","doi-asserted-by":"crossref","first-page":"e2114694","DOI":"10.1001\/jamanetworkopen.2021.14694","article-title":"Association of chemotherapy, enzalutamide, abiraterone, and radium 223 with cognitive function in older men with metastatic castration-resistant prostate cancer","volume":"4","author":"Alibhai","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456923000834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456923000834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:54:04Z","timestamp":1762498444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456923000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2405456923000834"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2023.03.015","relation":{},"ISSN":["2405-4569"],"issn-type":[{"type":"print","value":"2405-4569"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Confusion Surrounding Androgen Deprivation Therapy and Cognitive Dysfunction","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2023.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}